FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085080249> ?p ?o ?g. }

• W3085080249 endingPage "7634" @default.
• W3085080249 startingPage "7608" @default.
• W3085080249 abstract "A new series of pyrimidine-5-carbonitrile derivatives has been designed as ATP mimicking tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR). These compounds were synthesized and evaluated for their in vitro cytotoxic activities against a panel of four human tumor cell lines, namely colorectal carcinoma (HCT-116), hepatocellular carcinoma (HepG-2), breast cancer (MCF-7), and non-small cell lung cancer cells (A549). Five of the synthesized compounds, 11a, 11b, 12b, 15b and 16a, were found to exhibit moderate antiproliferative activity against the tested cell lines and were more active than the EGFR inhibitor erlotinib. In particular, compound 11b showed 4.5- to 8.4-fold erlotinib activity against HCT-116, HepG-2, MCF-7, and A549 cells with IC50 values of 3.37, 3.04, 4.14, and 2.4 μM respectively. Moreover, the most cytotoxic compounds that showed promising IC50 values against the four cancer cell lines were subjected to further investigation for their kinase inhibitory activities against EGFRWT and EGFRT790M using homogeneous time resolved fluorescence (HTRF) assay. Compound 11b was also found to be the most active compound against both EGFRWT and mutant EGFRT790M, exhibiting IC50 values of 0.09 and 4.03 μM, respectively. The cell cycle and apoptosis analyses revealed that compound 11b can arrest the cell cycle at the G2/M phase and induce significant apoptotic effects in HCT-116, HepG-2, and MCF-7 cells. Additionally, compound 11b upregulated the level of caspase-3 by 6.5 fold in HepG-2 when compared with the control. Finally, molecular docking studies were carried out to examine the binding mode of the synthesized compounds against the proposed targets; EGFRWT and EGFRT790M. Additional in silico ADMET studies were performed to explore drug-likeness properties." @default.
• W3085080249 created "2020-09-21" @default.
• W3085080249 creator A5007786874 @default.
• W3085080249 creator A5012093994 @default.
• W3085080249 creator A5016921887 @default.
• W3085080249 creator A5020589815 @default.
• W3085080249 creator A5027623696 @default.
• W3085080249 creator A5035318866 @default.
• W3085080249 creator A5044030554 @default.
• W3085080249 creator A5044244955 @default.
• W3085080249 creator A5051612519 @default.
• W3085080249 creator A5055998450 @default.
• W3085080249 creator A5072286861 @default.
• W3085080249 creator A5075151420 @default.
• W3085080249 creator A5085100247 @default.
• W3085080249 date "2020-01-01" @default.
• W3085080249 modified "2023-10-17" @default.
• W3085080249 title "Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR^WTand EGFR^T790M" @default.
• W3085080249 cites W1500827124 @default.
• W3085080249 cites W1629179716 @default.
• W3085080249 cites W180401638 @default.
• W3085080249 cites W1963739452 @default.
• W3085080249 cites W1967276277 @default.
• W3085080249 cites W1967912613 @default.
• W3085080249 cites W1972692044 @default.
• W3085080249 cites W1976189767 @default.
• W3085080249 cites W1979449084 @default.
• W3085080249 cites W1982044762 @default.
• W3085080249 cites W1983790923 @default.
• W3085080249 cites W1985194885 @default.
• W3085080249 cites W1989911225 @default.
• W3085080249 cites W1998110165 @default.
• W3085080249 cites W2001247454 @default.
• W3085080249 cites W2002937040 @default.
• W3085080249 cites W2003984225 @default.
• W3085080249 cites W2007012742 @default.
• W3085080249 cites W2018711732 @default.
• W3085080249 cites W2020261641 @default.
• W3085080249 cites W2035105910 @default.
• W3085080249 cites W2044114966 @default.
• W3085080249 cites W2045809294 @default.
• W3085080249 cites W2054231318 @default.
• W3085080249 cites W2055622791 @default.
• W3085080249 cites W2057166163 @default.
• W3085080249 cites W2063391304 @default.
• W3085080249 cites W2064973618 @default.
• W3085080249 cites W2066060241 @default.
• W3085080249 cites W2076178766 @default.
• W3085080249 cites W2077804275 @default.
• W3085080249 cites W2078532650 @default.
• W3085080249 cites W2079398727 @default.
• W3085080249 cites W2085126121 @default.
• W3085080249 cites W2088483249 @default.
• W3085080249 cites W2091399843 @default.
• W3085080249 cites W2097699101 @default.
• W3085080249 cites W2107102981 @default.
• W3085080249 cites W2109080255 @default.
• W3085080249 cites W2109912135 @default.
• W3085080249 cites W2110841878 @default.
• W3085080249 cites W2114918609 @default.
• W3085080249 cites W2116247728 @default.
• W3085080249 cites W2121389354 @default.
• W3085080249 cites W2122216528 @default.
• W3085080249 cites W2123206362 @default.
• W3085080249 cites W2123555204 @default.
• W3085080249 cites W2128306375 @default.
• W3085080249 cites W2128408225 @default.
• W3085080249 cites W2142847551 @default.
• W3085080249 cites W2156373035 @default.
• W3085080249 cites W2166689953 @default.
• W3085080249 cites W2169816570 @default.
• W3085080249 cites W2327002369 @default.
• W3085080249 cites W2395523735 @default.
• W3085080249 cites W2411726279 @default.
• W3085080249 cites W2418046358 @default.
• W3085080249 cites W2418540139 @default.
• W3085080249 cites W2473328171 @default.
• W3085080249 cites W2517817365 @default.
• W3085080249 cites W2519105450 @default.
• W3085080249 cites W2524297231 @default.
• W3085080249 cites W2587397432 @default.
• W3085080249 cites W2593093801 @default.
• W3085080249 cites W2599817836 @default.
• W3085080249 cites W2619714025 @default.
• W3085080249 cites W2733930358 @default.
• W3085080249 cites W2734066598 @default.
• W3085080249 cites W2735225452 @default.
• W3085080249 cites W2740059367 @default.
• W3085080249 cites W2749897366 @default.
• W3085080249 cites W2750145485 @default.
• W3085080249 cites W2769328077 @default.
• W3085080249 cites W2791416170 @default.
• W3085080249 cites W2796152634 @default.
• W3085080249 cites W2805634574 @default.
• W3085080249 cites W2808351871 @default.
• W3085080249 cites W2809674728 @default.
• W3085080249 cites W2817198669 @default.
• W3085080249 cites W2887271393 @default.

• next